Explore the Potential with AI-Driven Innovation
Our detailed focused library is generated on demand with advanced virtual screening and parameter assessment technology powered by the Receptor.AI drug discovery platform. This method surpasses traditional approaches, delivering compounds of better quality with enhanced activity, selectivity, and safety.
Our selection of compounds is from a large virtual library of over 60 billion molecules. The production and distribution of these compounds are managed by our partner Reaxense.
In the library, a selection of top modulators is provided, each marked with 38 ADME-Tox and 32 parameters related to physicochemical properties and drug-likeness. Also, every compound comes with its best docking poses, affinity scores, and activity scores, providing a comprehensive overview.
Our high-tech, dedicated method is applied to construct targeted libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
The procedure entails thorough molecular simulations of the catalytic and allosteric binding pockets, accompanied by ensemble virtual screening that factors in their conformational flexibility. When developing modulators, the structural modifications brought about by reaction intermediates are factored in to optimize activity and selectivity.
Several key aspects differentiate our library:
partner
Reaxense
upacc
Q96BZ4
UPID:
PLD4_HUMAN
Alternative names:
Choline phosphatase 4; Phosphatidylcholine-hydrolyzing phospholipase D4; Phospholipase D family member 4; Phospholipase D4
Alternative UPACC:
Q96BZ4; Q6UWD2
Background:
5'-3' exonuclease PLD4, also known as Choline phosphatase 4, plays a crucial role in DNA repair by digesting single-stranded DNA. It regulates inflammatory responses by degrading nucleic acids, thus reducing ssDNA concentrations that stimulate TLR9, a key nucleotide-sensing receptor. Additionally, it is involved in the phagocytosis process of activated microglia.
Therapeutic significance:
Understanding the role of 5'-3' exonuclease PLD4 could open doors to potential therapeutic strategies, particularly in modulating inflammatory responses and enhancing DNA repair mechanisms.